Medipass : Providing Pharmaceutical Guidance Services for Roche Korea

Hello, this is the Weavrcare team.

We are pleased to announce the successful launch and completion of testing for the medication guidance service for patients provided by Weavrcare in partnership with the global pharmaceutical company Roche Korea. Weavrcare and Roche signed their initial contract in December 2022, commencing this project, which has now been successfully developed and renewed in 2023.

This project entails the provision of a real service through Medipass, Weavrcare’s patient-centric medical information mobile app, allowing individuals to access and manage information about Roche medications prescribed to them. Individuals can receive guidance on the usage, side effects, and precautions of medications prescribed at hospitals integrated with Medipass. Instead of relying on paper leaflets, which are prone to loss or misplacement, individuals can now store and reference medication information conveniently on their mobile devices, bringing significant convenience to their daily lives.

Through this collaboration with Roche and the implementation of this project, patients can now receive accurate and reliable information about their prescribed medications more conveniently and safely. Building upon this foundation, we will continue to collaborate with various institutions and businesses to establish a data ecosystem for the benefit of patients.

In the future, Weavrcare will innovate healthcare services from a perspective that encompasses all stakeholders, including suppliers and consumers, leveraging the latest technologies.

Thank you

Healthcare redefined, Weavrcare